<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04632147</url>
  </required_header>
  <id_info>
    <org_study_id>59491012-604.01.02</org_study_id>
    <nct_id>NCT04632147</nct_id>
  </id_info>
  <brief_title>The Effect of Pranayamic Techniques on Obstructive Sleep Apnea Syndrome</brief_title>
  <official_title>The Effect of Pranayamic Techniques on Obstructive Sleep Apnea Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istanbul University-Cerrahpasa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istanbul University-Cerrahpasa</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study was planned to investigate the effect of pranayama on dyspnea, daytime sleepiness,&#xD;
      cognitive function, quality of life, activities of daily living, functional exercise&#xD;
      capacity, physical activity level, sleep quality, fatigue, musculoskeletal pain, depression&#xD;
      and anxiety in OSAS.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Thirty-four OSAS patients meeting the inclusion criteria will be randomized into 2 groups as&#xD;
      pranayama and control groups. The pranayama group will practice pranayama on their own for 8&#xD;
      weeks, 7 days a week, 3 times a day for 15 minutes. In addition, he will perform a single&#xD;
      15-minute session 3 days a week online under the supervision of a physiotherapist. The&#xD;
      control group will not receive any intervention. Dyspnea sensation before and after the&#xD;
      training Modified Medical Research Council dyspnea scale, daytime sleepiness Epworth&#xD;
      Sleepiness Scale, cognitive function Montreal Cognitive Assessment Scale, quality of life&#xD;
      Short Form-36, Turkish Adaptation of Nottingham Health Profile Questionnaire and Functional&#xD;
      Outcomes of Sleep Questionnaire, activities of daily living London Chest Activities of Daily&#xD;
      Living Scale, functional exercise capacity 30 seconds sit and stand test, physical activity&#xD;
      level International Physical Activity Questionnaire-Short Form, sleep quality Pittsburgh&#xD;
      Sleep Quality Index, fatigue status Fatigue Severity Scale, depression and anxiety Hospital&#xD;
      Anxiety and Depression Scale, musculoskeletal system pain will be assessed with the Nordic&#xD;
      Musculoskeletal Questionnaire.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 20, 2021</start_date>
  <completion_date type="Anticipated">September 25, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 20, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Participants will be randomly divided into two groups as pranayama group and control group.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Vital Capacity</measure>
    <time_frame>8 weeks</time_frame>
    <description>Vital capacity will be measured in liters, which is one of the respiratory functions.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Functional Exercise Capacity</measure>
    <time_frame>8 weeks</time_frame>
    <description>It will be evaluated by the 6-minute walking test.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Dyspnoea</measure>
    <time_frame>8 weeks</time_frame>
    <description>The resting dyspnea level will be evaluated according to the Modified Borg Scale.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>fatigue</measure>
    <time_frame>8 weeks</time_frame>
    <description>Fatigue level will be assessed using the Fatigue Severity Scale (FSS).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Anxiety and Depression Status</measure>
    <time_frame>8 weeks</time_frame>
    <description>It will be evaluated with the Hospital Anxiety Depression Scale.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Physical Activity Level</measure>
    <time_frame>8 weeks</time_frame>
    <description>It will be evaluated with the International Physical Activity Questionnaire-Short form (IPAQ-S).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cognitive Function</measure>
    <time_frame>8 weeks</time_frame>
    <description>Cognitive evaluation of the patients will be made with the Montreal Cognitive Assessment Scale (MOCA).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Daily Life Activities</measure>
    <time_frame>8 weeks</time_frame>
    <description>Daily life activities will be evaluated with the London Chest Daily Living Activities Scale.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Daytime Sleepiness</measure>
    <time_frame>8 weeks</time_frame>
    <description>Daytime sleepiness will be assessed with the Epworth Sleepiness Scale (ESS).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sleep Quality</measure>
    <time_frame>8 weeks</time_frame>
    <description>Sleep quality will be evaluated with the Pittsburg Sleep Quality Index (PSQI).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Life Quality</measure>
    <time_frame>8 weeks</time_frame>
    <description>Quality of life will be evaluated with the SF-36 scale.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Inspiratory Muscle Strength</measure>
    <time_frame>8 weeks</time_frame>
    <description>Inspiratory muscle strength will be evaluated by measuring the maximum inspiratory pressure (MIP) in cmH2O.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Forced Vital Capacity</measure>
    <time_frame>8 weeks</time_frame>
    <description>Forced Vital Capacity will be measured in liters, which is one of the respiratory functions.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Expiratory Muscle Strength</measure>
    <time_frame>8 weeks</time_frame>
    <description>Expiratory muscle strength will be evaluated by measuring the maximum expiratory pressure (MIP) in cmH2O.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">34</enrollment>
  <condition>Obstructive Sleep Apnea Syndrome</condition>
  <arm_group>
    <arm_group_label>Pranayama Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this group will apply a 45-minute training program at home, consisting of 5 minutes of Ujjayi pranayama, 5 minutes of Nadi-Shodhana pranayama and 5 minutes of Sukha pranayama, 7 days a week for 8 weeks, 3 times a day. In addition, they will perform a 15-minute session 3 day a week for 8 weeks, under the online supervision of a physiotherapist. The training program will last 8 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No intervention will be made to this group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Ujjayi pranayama, Nadi-Shodhana pranayama, Sukha pranayama</intervention_name>
    <description>Ujjayi pranayama:It is a pranayamic application that is performed by slightly twisting the throat and breathing through the nose. Nadi shodhana pranayama is breathing alternately through the right and left nostrils.Sukha pranayama is inhaled through the nose for 5 seconds, then given through the nose for 5 seconds. Thus, 6 times of inspiration and expiration is done per minute.</description>
    <arm_group_label>Pranayama Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients diagnosed with mild to moderate obstructive sleep apnea syndrome.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Using a mandibular advancement device&#xD;
&#xD;
          -  Regularly using hypnotic drugs&#xD;
&#xD;
          -  Have a metabolic disease (eg diabetes, hypothyroidism, obesity)&#xD;
&#xD;
          -  Have Hypertension&#xD;
&#xD;
          -  Have Malignancy&#xD;
&#xD;
          -  Have Epilepsy&#xD;
&#xD;
          -  Have Heart failure&#xD;
&#xD;
          -  Have COPD&#xD;
&#xD;
          -  Have asthma&#xD;
&#xD;
          -  Neurological, psychological, cooperative problems&#xD;
&#xD;
          -  Having a history of maxillofacial surgery&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rengin Demir</last_name>
    <role>Study Chair</role>
    <affiliation>Istanbul University Cerrahpasa Cardiology Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ömer Önder Önder</last_name>
    <role>Study Chair</role>
    <affiliation>Istanbul Esenyurt University Health Science Faculty</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ersan Atahan</last_name>
    <role>Study Chair</role>
    <affiliation>Istanbul University Cerrahpasa Faculty of Medicine Department of Chest Diseases</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Zeynep Kaçar</name>
      <address>
        <city>Istanbul</city>
        <state>Türkiye</state>
        <zip>3451</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Armutlu K, Korkmaz NC, Keser I, Sumbuloglu V, Akbiyik DI, Guney Z, Karabudak R. The validity and reliability of the Fatigue Severity Scale in Turkish multiple sclerosis patients. Int J Rehabil Res. 2007 Mar;30(1):81-5.</citation>
    <PMID>17293726</PMID>
  </reference>
  <reference>
    <citation>Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003 Aug;35(8):1381-95.</citation>
    <PMID>12900694</PMID>
  </reference>
  <reference>
    <citation>Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005 Apr;53(4):695-9. Erratum in: J Am Geriatr Soc. 2019 Sep;67(9):1991.</citation>
    <PMID>15817019</PMID>
  </reference>
  <reference>
    <citation>Garrod R, Bestall JC, Paul EA, Wedzicha JA, Jones PW. Development and validation of a standardized measure of activity of daily living in patients with severe COPD: the London Chest Activity of Daily Living scale (LCADL). Respir Med. 2000 Jun;94(6):589-96.</citation>
    <PMID>10921765</PMID>
  </reference>
  <reference>
    <citation>Polkey MI, Green M, Moxham J. Measurement of respiratory muscle strength. Thorax. 1995 Nov;50(11):1131-5. Review.</citation>
    <PMID>8553266</PMID>
  </reference>
  <results_reference>
    <citation>Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14(5):377-81.</citation>
    <PMID>7154893</PMID>
  </results_reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>October 22, 2020</study_first_submitted>
  <study_first_submitted_qc>November 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 17, 2020</study_first_posted>
  <last_update_submitted>September 9, 2021</last_update_submitted>
  <last_update_submitted_qc>September 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istanbul University-Cerrahpasa</investigator_affiliation>
    <investigator_full_name>Zeynep KAÇAR</investigator_full_name>
    <investigator_title>physiotherapist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Participants' age, gender, general health status, respiratory functions, functional exercise capacity, dyspnea level, fatigue severity, anxiety and depression status, physical activity level, cognitive function, daily living activities, daytime sleepiness, daily living activities, quality of life, respiratory muscle Data such as strength will be shared with other researchers. Other researchers will be able to obtain these data of the participants both before and after the intervention.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>starting 6 months after publication</ipd_time_frame>
    <ipd_access_criteria>IPD will be shared with all researchers in the study.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

